IL309179A - Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their uses - Google Patents
Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their usesInfo
- Publication number
- IL309179A IL309179A IL309179A IL30917923A IL309179A IL 309179 A IL309179 A IL 309179A IL 309179 A IL309179 A IL 309179A IL 30917923 A IL30917923 A IL 30917923A IL 309179 A IL309179 A IL 309179A
- Authority
- IL
- Israel
- Prior art keywords
- klk2
- nucleic acid
- fusion protein
- recombinant cells
- acid coding
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21035—Tissue kallikrein (3.4.21.35)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
- C07K2319/912—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation containing a GPI (phosphatidyl-inositol glycane) anchor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209019P | 2021-06-10 | 2021-06-10 | |
| PCT/IB2022/055355 WO2022259190A1 (en) | 2021-06-10 | 2022-06-08 | Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309179A true IL309179A (en) | 2024-02-01 |
Family
ID=82358484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309179A IL309179A (en) | 2021-06-10 | 2022-06-08 | Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their uses |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220403397A1 (enExample) |
| EP (1) | EP4352217A1 (enExample) |
| JP (1) | JP2024520790A (enExample) |
| KR (1) | KR20240021211A (enExample) |
| CN (1) | CN117480253A (enExample) |
| AU (1) | AU2022291273A1 (enExample) |
| BR (1) | BR112023025616A2 (enExample) |
| CA (1) | CA3222756A1 (enExample) |
| IL (1) | IL309179A (enExample) |
| MX (1) | MX2023014793A (enExample) |
| WO (1) | WO2022259190A1 (enExample) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| GB8901778D0 (en) | 1989-01-27 | 1989-03-15 | Univ Court Of The University O | Manipulatory technique |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
| US5602299A (en) | 1992-09-23 | 1997-02-11 | Mount Sinai School Of Medicine Of The City University Of New York | Transgenic animal models for neurodegenerative disease |
| EP1024198A3 (en) | 1992-12-03 | 2002-05-29 | Genzyme Corporation | Pseudo-adenoviral vectors for the gene therapy of haemophiliae |
| EP0705344B8 (en) | 1993-06-24 | 2006-05-10 | Advec Inc. | Adenovirus vectors for gene therapy |
| US5516639A (en) * | 1993-07-22 | 1996-05-14 | Mayo Foundation For Medical Education And Research | Antibodies specific for human prostate glandular kallkrein |
| AU687117B2 (en) | 1993-10-25 | 1998-02-19 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
| JPH07132033A (ja) | 1993-11-12 | 1995-05-23 | Hoechst Japan Ltd | アルツハイマー病モデルトランスジェニック動物 |
| US6113917A (en) * | 1995-04-25 | 2000-09-05 | Rmf Dictagene S.A. | Modified polypeptides for enhanced immunogenicity |
| US6066778A (en) | 1996-11-06 | 2000-05-23 | The Regents Of The University Of Michigan | Transgenic mice expressing APC resistant factor V |
| DK1716233T3 (da) * | 2004-01-30 | 2009-10-26 | Maxygen Holdings Ltd | Reguleret stopkodongennemlæsning |
| AU2005295421A1 (en) * | 2004-10-18 | 2006-04-27 | Zymogenetics, Inc. | Soluble Zcytor21, anti-Zcytor21 antibodies and binding partners and methods of using in inflammation |
| EP2315846A4 (en) * | 2008-08-05 | 2011-11-30 | Univ Rochester | PSA AND KLK2 AS THERAPEUTIC TARGET MOLECULES AND PSA AND KLK2-INHIBITABLE MOLECULES |
| WO2012068317A2 (en) * | 2010-11-16 | 2012-05-24 | Excelimmune, Inc. | Methods for producing recombinant proteins |
| JP7235436B2 (ja) * | 2014-11-10 | 2023-03-08 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 細胞の表面上にポリペプチドを発現させるための組成物および方法 |
| AU2020322221A1 (en) * | 2019-07-26 | 2022-03-24 | Janssen Biotech, Inc. | Anti-hK2 chimeric antigen receptor (CAR) |
-
2022
- 2022-06-08 KR KR1020247000497A patent/KR20240021211A/ko active Pending
- 2022-06-08 CA CA3222756A patent/CA3222756A1/en active Pending
- 2022-06-08 AU AU2022291273A patent/AU2022291273A1/en active Pending
- 2022-06-08 WO PCT/IB2022/055355 patent/WO2022259190A1/en not_active Ceased
- 2022-06-08 JP JP2023575724A patent/JP2024520790A/ja active Pending
- 2022-06-08 MX MX2023014793A patent/MX2023014793A/es unknown
- 2022-06-08 BR BR112023025616A patent/BR112023025616A2/pt not_active Application Discontinuation
- 2022-06-08 EP EP22735984.1A patent/EP4352217A1/en active Pending
- 2022-06-08 IL IL309179A patent/IL309179A/en unknown
- 2022-06-08 CN CN202280041004.7A patent/CN117480253A/zh active Pending
- 2022-06-08 US US17/835,671 patent/US20220403397A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4352217A1 (en) | 2024-04-17 |
| CN117480253A (zh) | 2024-01-30 |
| MX2023014793A (es) | 2024-03-25 |
| US20220403397A1 (en) | 2022-12-22 |
| AU2022291273A1 (en) | 2024-01-25 |
| KR20240021211A (ko) | 2024-02-16 |
| BR112023025616A2 (pt) | 2024-02-27 |
| WO2022259190A1 (en) | 2022-12-15 |
| CA3222756A1 (en) | 2022-12-15 |
| JP2024520790A (ja) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501413A1 (en) | T-cell modulatory multimeric polypeptides and method of use thereof | |
| WO2022056254A3 (en) | Dna modifying enzymes and active fragments and variants thereof and methods of use | |
| WO2017151940A3 (en) | T-cell modulatory multimeric polypeptides and methods of use thereof | |
| AU2017266905A1 (en) | Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof | |
| SG11202006431WA (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| WO2010082804A3 (en) | Method for producing physiologically active protein or peptide using immunoglobulin fragment | |
| MX2021000263A (es) | Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma. | |
| WO2004099370A3 (en) | NOVEL BACILLUS mHKcel CELLULASE | |
| WO2014118360A3 (en) | Carbohydrate degrading polypeptide and uses thereof | |
| BR112022006842A2 (pt) | Construtos de igf2 variante | |
| WO2016130628A8 (en) | Griffithsin mutants | |
| WO2019084362A3 (en) | Fusion protein and nucleic acid molecule for exogenous stimulant-dependent stress granule assembly | |
| WO2014150748A3 (en) | Stabilized single human cd4 domains and fusion proteins | |
| GB2614158B (en) | Nucleic acid constructs for expressing polypeptides in cells | |
| EP3976104A4 (en) | ANTI-CSF1R ANTIBODIES, IL10 FUSION PROTEINS AND THEIR USES | |
| SG11202009503PA (en) | Engineered cells with modified host cell protein profiles | |
| HK1250992A1 (zh) | 表皮生长因子受体变体iii-间皮素融合物及其使用方法 | |
| IL309179A (en) | Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their uses | |
| HK40109642A (en) | Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof | |
| WO2013070796A3 (en) | Propeptide-luciferase fusion proteins and methods of use thereof | |
| IL319272A (en) | ROVEL FUSION protein specific for CD137 and CD228 | |
| ZA201105921B (en) | Fusion proteins,preparation process thereof and their use in recombinant protein expression systems | |
| GB202209517D0 (en) | Modified fusion proteins and nucleic acid constructs | |
| ZA202110190B (en) | Protein tapyl1, coding gene and use thereof | |
| GB202307936D0 (en) | Fusion protein |